Clinical Trial Update: Chronic Exogenous Ketosis in HFpEF [Phase 2]

View source ↗

Summary

Phase 2 study evaluating chronic exogenous ketosis in heart failure with preserved ejection fraction, currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction

Snippet

Sponsor: Duke University | Conditions: Heart Failure With Preserved Ejection Fraction (HFPEF), Heart Failure With Normal Ejection Fraction | Phase 2 | Status: ENROLLING_BY_INVITATION